VAIA
GBT

Virtus Alternative Investment Advisers’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Virtus Alternative Investment Advisers’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-105
Closed -$5K – 258
2020
Q4 		$5K Sell
105
-101
-49% -$4.98K 0.07% 272
2020
Q3 		$11K Sell
206
-16
-7% -$1.02K 0.2% 241
2020
Q2 		$14K Sell
222
-207
-48% -$14.2K 0.22% 176
2020
Q1 		$22K Buy
429
+269
+168% +$18K 0.3% 167
2019
Q4 		$13K Buy
+160
New +$9.48K 0.2% 12

Other funds holding GBT

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Virtus Alternative Investment Advisers's GBT Position: Q1 2021 in Review

Virtus Alternative Investment Advisers sold out of Global Blood Therapeutics, Inc. (GBT) in Q1 2021, closing a stake of 105 shares — an estimated $5K sold.

Virtus Alternative Investment Advisers first reported a position in GBT in Q4 2019 and held it in 5 quarters. The position peaked at $22K in Q1 2020. 214 funds tracked by Wall St. Rank hold GBT as of Q1 2021.

  • Virtus Alternative Investment Advisers reported no remaining Global Blood Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
  • Virtus Alternative Investment Advisers sold 105 Global Blood Therapeutics, Inc. shares in Q1 2021, an estimated $5K.
  • Virtus Alternative Investment Advisers first reported a position in Global Blood Therapeutics, Inc. in Q4 2019 and held it in 5 quarters.
  • Virtus Alternative Investment Advisers's Global Blood Therapeutics, Inc. position peaked at $22K in Q1 2020.
  • 214 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2021.

Based on Virtus Alternative Investment Advisers's 13F filing for Q1 2021.